RECURSION PHARMACEUTICALS, INC. - CL A (RXRX)

Historical Portfolio Holders from Q1 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / CL A
Shares, excl. options Q1 2024
207 M
Holdings value Q1 2024
$2.07 B
Value change Q1 2024
+$37.8 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
233
Number of buys Q1 2024
147
Number of sells Q1 2024
-66
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
75629V104
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 207 M $2.07 B +$37.8 M $9.97 233
2023 Q4 204 M $2.01 B +$323 M $9.86 192
2023 Q3 149 M $1.14 B +$184 M $7.65 187
2023 Q2 125 M $930 M -$5.48 M $7.47 149
2023 Q1 126 M $841 M +$15 M $6.67 156
2022 Q4 124 M $953 M +$135 M $7.71 140
2022 Q3 112 M $1.19 B +$75.1 M $10.64 134
2022 Q2 103 M $842 M +$96.4 M $8.14 126
2022 Q1 94.8 M $679 M -$13.1 M $7.16 117
2021 Q4 87.4 M $1.5 B +$283 M $17.13 118
2021 Q3 54.9 M $1.26 B +$181 M $23.01 83
2021 Q2 47 M $1.71 B +$1.71 B $36.50 77
2021 Q1 30 $1 K $0 $33.33 1